The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs that has revolutionized obesity treatment. The drug, which Novo Nordisk calls simply the Wegovy pill, uses the same active ingredient – | Read More in Virtual Jerusalem